CIK 0001699382
- Non-accelerated filer
- Smaller reporting company
PMV Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PMVP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463218129
- Phone
- +1 609-642-6670
- Business address
- 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
- 4 Grant or award Chief Development Officer acquired 95,555 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 82,220 shares (grant or award)
- 4 Grant or award President and CEO acquired 163,890 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 87,786 shares at $2.23 ($195,763)
- 4 Option exercise President and CEO acquired 198,407 shares (option exercise)
- 4 Open-market sale Chief Development Officer sold 4,104 shares at $6.62 ($27,168)
- 4 Open-market sale Chief Medical Officer sold 6,291 shares at $6.62 ($41,646)
- 4 Option exercise President and CEO acquired 85,500 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Gift COO, CFO gave 2,560 shares (gift)
Page 3 of 10 · 190 filings